What if we could stop Alzheimer's before it ever starts?
Maritza Ciliberto is participating in an experimental, long-term clinical trial involving anti-amyloid treatments to prevent Alzheimer's disease before symptoms appear. Her family history of early-onset Alzheimer's drives her commitment to this rigorous and potentially risky medical routine.
Why it matters
It explores the cutting edge of preventative medicine and the high personal stakes involved in testing treatments for genetically inherited neurodegenerative diseases.
Maritza Ciliberto, 57, has been on anti-amyloid treatments for over a decade. Can they prevent her from developing dementia? Hannah Latham for BI Growing up in Guayama, a town nicknamed "witch city" in Puerto Rico, Maritza Ciliberto heard the rumors that her family was cursed. She didn't believe in curses, rejecting the idea that anyone could ever deserve to get sick, but she did believe there was something lurking in her relatives' brains — a "sleeping, giant monster" waiting to emerge. First, it came for her grandmother, who struggled with daily chores. Then her mother, who began repeating the same questions over and over. Eventually, her mother, two of her aunts, and one uncle died from a rare and inherited form of early-onset Alzheimer's disease due to a genetic mutation. Ciliberto knew she could be next.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in